During Monday's early US trading session, shares of regenerative medicine company Avita Medical Ltd. (RCEL) surged 35% following the company's announcement that its RECELL GO device received CE certification, initially driving the stock up 10%. The device is designed to help treat acute traumatic injuries and will expand Avita Medical Ltd.'s business operations in the European medical market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.